Both in Pharmaceuticals
Boundless Bio vs Xilio Therapeutics
Over the past year BOLD returned +84.6% and XLO returned −22.4%; their daily moves had a correlation of -0.00.
BOLD +84.6% XLO −22.4%Growth of $1, one year, split-adjusted
| Metric | BOLD | XLO |
|---|---|---|
| Price | $2.40 | $8.71 |
| Market cap | $55.5M | $57.3M |
| Today | +0.84% | +0.35% |
| 1 month | −6.6% | −3.2% |
| 6 months | +51.9% | +10.3% |
| Year to date | +100.0% | −2.8% |
| 1 year | +75.2% | −26.8% |
| Revenue growth (YoY) | — | +131.2% |
| Gross margin | — | 100.0% |
| Net margin | — | −34.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.9× |
| Net cash | $72.6M | $136.0M |
| Dividend yield | — | — |
| Volatility (60d) | 31.5% | 38.3% |
| Short % of float | 7.0% | 10.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).